1. Tasian GE, Copelovitch L, Plachter N, Ashcroft K, et al. Outpatient clinical pathway for the evaluation/treatment of child with nephrolithiasis. Children’s Hospital of Philadelphia Center for Healthcare Quality and Analytics; 2013. https://www.chop.edu/clinical-pathway/nephrolithiasis-outpatient-specialty-care-clinical-pathway
2. Persaud AC, Stevenson MD, McMahon DR, Christopher NC. Pediatric urolithiasis: clinical predictors in the emergency department. Pediatrics. 2009;124(3):888–94.
3. Zonfrillo M, Lavelle J, Piro J, Kim S, Darge K. ED pathway for evaluation and treatment of children with suspected nephrolithiasis. Children’s Hospital of Philadelphia Center for Healthcare Quality and Analytics; 2018. https://www.chop.edu/clinical-pathway/nephrolithiasis-suspected-emergent-care-clinical-pathway
4. Shorvon SD. Safety of topiramate: adverse events and relationships to dosing. Epilepsia. 1996;37(Suppl 2):S18–22.
5. Tasian GE, Jemielita T, Goldfarb DS, et al. Oral antibiotic exposure and kidney stone disease. J Am Soc Nephrol. 2018;29:1731.